Long-Term Risk of Malignant Neoplasm Associated with Gestational Glucose Intolerance

Cancer

Volumn 100, Issue 1, 2004, Pages 149-155

  Dawson, Shelagh I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cancer risk; Follow up study; Malignant neoplasm; Maternal glucose intolerance

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BODY WEIGHT; CANCER RISK; CIGARETTE SMOKING; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PREGNANCY; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; NEOPLASMS; PREGNANCY; RISK FACTORS;

EID: 0346217043     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20013     Document Type: Article

References (33)

1. Coustan DR. Diagnosis of gestational diabetes. What are our objectives? Diabetes. 1991;40(S2):14-17.
2. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care. 1980;3(S3):458-464.
3. Coustan DR. Screening and testing for gestational diabetes mellitus. Obstet Gynecol Clin North Am. 1996;23(1):125-136.
4. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet. 1980;I:1373-1376.
5. Singer DE, Nathan DM, Anderson KM, Wilson PWR, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham heart study. Diabetes. 1992;41:202-208.
6. Barrett-Connor E, Wingard D, Criqui MH, Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chronic Dis. 1984;37:773-779.
7. Scheidt-Nave C, Barrett-Connor E, Wingard D, Cohn BA, Edelstein SL. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol. 1991;133:565-576.
8. Ellinger F, Landsman H. Frequency and course of cancer in diabetics. N Y State J Med. 1944;44:259-265.
9. Jacobsen PH. A statistical study of cancer among diabetics. Millbank Mem Fund Q. 1948;26:90-118.
10. Marks PA, Bishop J. Alteration in carbohydrate metabolism associated with neoplasia in man. ProcAm Assoc Cancer Res. 1956-1970.
11. Lisker SA, Brody JI, Beizer LH. Abnormal carbohydrate in patients with malignant blood dyscrasies. Am J Med Sci. 1966;252:282-288.
12. Edmonson JH. Fatty acid mobilization and glucose metabolism patients with cancer. Cancer. 1966;19:277-280.
13. Glicksman AS, Rawson RW. Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer. 1956;9:1127-1134.
14. Glicksman AS, Meyers WPL, Rawson RW. Diabetes mellitus carbohydrate metabolism in patients with cancer. Med Clin North Am. 1956;40:887-900.
15. Ragozzino M, Melton LJ, Chu CP, Palumbo PI. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982;35:13-19.
16. Cohen FG. Early diagnosis of pancreatic neoplasms in diabetics. Lancet. 1965;2:267-269.
17. Wynder EL. A case control of cancer of the pancreas. Cancer. 1973;31:641-648.
18. Fraumeni J. Cancers of the pancreas and bilary tract: epidemiological considerations. Cancer Res. 1975;35:3437-3466.
19. Blot WJ, Fraumeni JF, Stone BJ. Geographic correlates of pancreatic cancer in the United States. Cancer. 1978;42:373-380.
20. Elmwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977;59:1055-1060.
21. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol. 1974;2:122-129.
22. Damon A. Host factors in cancer of the breast and uterine cervix and corpus. J Natl Cancer Inst. 1960;24:483-516.
23. Adami HO, Rimsten A. Prevalence of hypertension and diabetes in breast cancer: a case-control study in 179 patients and age-matched, non-hospitalized controls. Clin Oncol. 1978;4:243-249.
24. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis. 1985;38:435-441.
25. Paton A, Petch CP. Association of diabetes mellitus with cerebral tumor. BMJ 1954;4866:855-856.
26. Aronson SM, Aronson BE. Central nervous system in diabetes mellitus: lowered frequency of certain intracranial neoplasms. Arch Neurol. 1965;12:390-398.
27. Farmer G, Russell G, Hamilton-Nicol DR, et al. The influence of maternal glucose metabolism on fetal growth, development and morbidity in 917 singleton pregnancies in nondiabetic women. Diabetologia. 1988;31:134-141.
28. Kendrick S, Clarke J. The Scottish record-linkage system. Health Bull. 1993;51:72-79.
29. Wong JS, Pearson DW, Murchieson LE, Williams MJ, Narayan V. Mortality in diabetes mellitus: experience of a geographically defined population. Diabetic Med. 1991; 8(S2):135-139.
30. Lynch HT, Krush AJ, Larsen AI, Magnuson CW. Endometrial carcinoma, multiple primary malignancies, constitutional factors, and heredity. Am J Med Sci. 1966;252:381-390.
31. Benjamin F, Romney S. Disturbed carbohydrate metabolism in endometrial carcinoma. Cancer. 1964;17:386-90.
32. Deutsch S, Benjamin F. Effect of diabetic status on fractional estrogen levels in postmenopausal women. Am J Obstet Gynecol. 1978;120:105-106.
33. Quinn MA, Ruffe H, Brown JB, Ennis G. Circulating gonadotrophins and urinary estrogens in post-menopausal diabetic women. Aust N Z J Obstet Gynecol. 1981;21:234-236.